OptumLabs is using AI to predict Alzheimer's disease
November 21, 2018 / Susan Morse
This year, OptumLabs began a research project using artificial intelligence to predict Alzheimer's disease. The long-term project is being done in conjunction with a pharmaceutical company and other sponsors to identify clusters in a population at risk of developing Alzheimer's, which could lead to the development of a drug and clinical trials. "A lot of researchers are looking at genomics and genetic markers," OptumLabs CEO Paul Bleicher said. "We're approaching this from a different perspective," OptumLabs is the research and innovative collaborative within Optum.